U.S. flag

An official website of the United States government

Format

Send to:

Choose Destination

Refractory Anaplastic Oligodendroglioma

MedGen UID:
1716709
•Concept ID:
C5239365
•
Neoplastic Process

Definition

An anaplastic oligodendroglioma that is resistant to treatment. [from NCI]

Term Hierarchy

CClinical test,  RResearch test,  OOMIM,  GGeneReviews,  VClinVar  
  • CROGVRefractory Anaplastic Oligodendroglioma

Recent clinical studies

Etiology

Eslicarbazepine in patients with brain tumor-related epilepsy: a single-center experience.
Zoccarato M, Basile AM, Padovan M, Caccese M, Zagonel V, Lombardi G
Int J Neurosci 2021 Sep;131(9):879-884. Epub 2020 May 3 doi: 10.1080/00207454.2020.1759590. PMID: 32316814
Epilepsy surgery following brain tumor resection in children.
Tian AG, Edwards MS, Williams NJ, Olson DM
J Neurosurg Pediatr 2011 Mar;7(3):229-34. doi: 10.3171/2010.12.PEDS10293. PMID: 21361758
Bevacizumab for recurrent alkylator-refractory anaplastic oligodendroglioma.
Chamberlain MC, Johnston S
Cancer 2009 Apr 15;115(8):1734-43. doi: 10.1002/cncr.24179. PMID: 19197992
Fluid-attenuated inversion recovery ring sign as a marker of dysembryoplastic neuroepithelial tumors.
Parmar HA, Hawkins C, Ozelame R, Chuang S, Rutka J, Blaser S
J Comput Assist Tomogr 2007 May-Jun;31(3):348-53. doi: 10.1097/01.rct.0000243453.33610.9d. PMID: 17538277
Ganglioglioma: comparison with other low-grade brain tumors.
Brainer-Lima PT, Brainer-Lima AM, Azevedo-Filho HR
Arq Neuropsiquiatr 2006 Sep;64(3A):613-8. doi: 10.1590/s0004-282x2006000400018. PMID: 17119805

Diagnosis

Symptomatic Spinal Seeding Metastasis of a Low-grade Oligodendroglioma.
Keskin E, Aydin HA, Bahadir B, Simsek K, Kalayci M
J Coll Physicians Surg Pak 2022 Oct;32(10):1347-1349. doi: 10.29271/jcpsp.2022.10.1347. PMID: 36205285
Cranial and spinal oligodendrogliomatosis: a case report and review of the literature.
Lee SL, Wong A, Stadler JA 3rd, McClendon J Jr, Smith TR, Wadhwani NR, Tomita T
Childs Nerv Syst 2015 Jan;31(1):147-53. Epub 2014 Aug 26 doi: 10.1007/s00381-014-2506-4. PMID: 25155447
Ganglioglioma: comparison with other low-grade brain tumors.
Brainer-Lima PT, Brainer-Lima AM, Azevedo-Filho HR
Arq Neuropsiquiatr 2006 Sep;64(3A):613-8. doi: 10.1590/s0004-282x2006000400018. PMID: 17119805
Future directions for temozolomide therapy.
Yung WK
Semin Oncol 2001 Aug;28(4 Suppl 13):43-6. doi: 10.1016/s0093-7754(01)90070-3. PMID: 11550138
Meningioangiomatosis. A comprehensive analysis of clinical and laboratory features.
Wiebe S, Munoz DG, Smith S, Lee DH
Brain 1999 Apr;122 ( Pt 4):709-26. doi: 10.1093/brain/122.4.709. PMID: 10219783

Therapy

Systematic characterization of antibody-drug conjugate targets in central nervous system tumors.
Coy S, Lee JS, Chan SJ, Woo T, Jones J, Alexandrescu S, Wen PY, Sorger PK, Ligon KL, Santagata S
Neuro Oncol 2024 Mar 4;26(3):458-472. doi: 10.1093/neuonc/noad205. PMID: 37870091Free PMC Article
Eslicarbazepine in patients with brain tumor-related epilepsy: a single-center experience.
Zoccarato M, Basile AM, Padovan M, Caccese M, Zagonel V, Lombardi G
Int J Neurosci 2021 Sep;131(9):879-884. Epub 2020 May 3 doi: 10.1080/00207454.2020.1759590. PMID: 32316814
Bevacizumab and other novel therapies for recurrent oligodendroglial tumors.
Grimm SA, Chamberlain MC
CNS Oncol 2015;4(5):333-9. Epub 2015 Oct 28 doi: 10.2217/cns.15.27. PMID: 26509217Free PMC Article
Temozolomide and unusual indications: review of literature.
Tatar Z, Thivat E, Planchat E, Gimbergues P, Gadea E, Abrial C, Durando X
Cancer Treat Rev 2013 Apr;39(2):125-35. Epub 2012 Jul 19 doi: 10.1016/j.ctrv.2012.06.002. PMID: 22818211
Bevacizumab for recurrent alkylator-refractory anaplastic oligodendroglioma.
Chamberlain MC, Johnston S
Cancer 2009 Apr 15;115(8):1734-43. doi: 10.1002/cncr.24179. PMID: 19197992

Prognosis

Sustained response to erlotinib and rapamycin in a patient with pediatric anaplastic oligodendroglioma.
Geben LC, Mobley BC, Brockman AA, Pastakia D, Naftel R, Ihrie RA, Esbenshade AJ
Pediatr Blood Cancer 2021 Jan;68(1):e28750. Epub 2020 Oct 1 doi: 10.1002/pbc.28750. PMID: 33001573Free PMC Article
The Sensitive Detection of Telomerase Reverse Transcriptase Promoter Mutation by Amplification Refractory Mutation System-PCR.
Liu J, Zhao Z, Sun M, Chen K, Yuan W, Jiang G
Genet Test Mol Biomarkers 2016 Feb;20(2):90-3. Epub 2016 Jan 7 doi: 10.1089/gtmb.2015.0229. PMID: 26741813
Cranial and spinal oligodendrogliomatosis: a case report and review of the literature.
Lee SL, Wong A, Stadler JA 3rd, McClendon J Jr, Smith TR, Wadhwani NR, Tomita T
Childs Nerv Syst 2015 Jan;31(1):147-53. Epub 2014 Aug 26 doi: 10.1007/s00381-014-2506-4. PMID: 25155447
Intra-arterial chemotherapy with osmotic blood-brain barrier disruption for aggressive oligodendroglial tumors: results of a phase I study.
Guillaume DJ, Doolittle ND, Gahramanov S, Hedrick NA, Delashaw JB, Neuwelt EA
Neurosurgery 2010 Jan;66(1):48-58; discussion 58. doi: 10.1227/01.. PMID: 20023537Free PMC Article
Improving alloreactive CTL immunotherapy for malignant gliomas using a simulation model of their interactive dynamics.
Kronik N, Kogan Y, Vainstein V, Agur Z
Cancer Immunol Immunother 2008 Mar;57(3):425-39. Epub 2007 Sep 7 doi: 10.1007/s00262-007-0387-z. PMID: 17823798Free PMC Article

Clinical prediction guides

Symptomatic Spinal Seeding Metastasis of a Low-grade Oligodendroglioma.
Keskin E, Aydin HA, Bahadir B, Simsek K, Kalayci M
J Coll Physicians Surg Pak 2022 Oct;32(10):1347-1349. doi: 10.29271/jcpsp.2022.10.1347. PMID: 36205285
Phase 1 study of pomalidomide in children with recurrent, refractory, and progressive central nervous system tumors: A Pediatric Brain Tumor Consortium trial.
Fangusaro J, Mitchell DA, Kocak M, Robinson GW, Baxter PA, Hwang EI, Huang J, Onar-Thomas A, Dunkel IJ, Fouladi M, Warren KE
Pediatr Blood Cancer 2021 Feb;68(2):e28756. Epub 2020 Oct 7 doi: 10.1002/pbc.28756. PMID: 33025730Free PMC Article
The Sensitive Detection of Telomerase Reverse Transcriptase Promoter Mutation by Amplification Refractory Mutation System-PCR.
Liu J, Zhao Z, Sun M, Chen K, Yuan W, Jiang G
Genet Test Mol Biomarkers 2016 Feb;20(2):90-3. Epub 2016 Jan 7 doi: 10.1089/gtmb.2015.0229. PMID: 26741813
Epilepsia partialis continua responsive to intravenous levetiracetam.
Eggers C, Burghaus L, Fink GR, Dohmen C
Seizure 2009 Dec;18(10):716-8. doi: 10.1016/j.seizure.2009.09.005. PMID: 19836263
Improving alloreactive CTL immunotherapy for malignant gliomas using a simulation model of their interactive dynamics.
Kronik N, Kogan Y, Vainstein V, Agur Z
Cancer Immunol Immunother 2008 Mar;57(3):425-39. Epub 2007 Sep 7 doi: 10.1007/s00262-007-0387-z. PMID: 17823798Free PMC Article

Supplemental Content

Table of contents

    Practice guidelines

    • Bookshelf
      See practice and clinical guidelines in NCBI Bookshelf. The search results may include broader topics and may not capture all published guidelines. See the FAQ for details.

    Related information

    • PMC Articles
      Related information in PubMed Central Links
    • PubMed
      Related literature resources in PubMed

    Recent activity

    Clear Turn Off Turn On

    Your browsing activity is empty.

    Activity recording is turned off.

    Turn recording back on

    See more...